Verrica Pharmaceuticals (VRCA) executive compensation, 2026 proxy

Jayson Rieger, President and Chief Executive Officer, was paid $741,403 in fiscal 2025, down 40% from $1.2M the year before.

Filed
April 20, 2026
Annual meeting
June 5, 2026
Pay year
fiscal 2025
Named executives
5
CEO total pay
$741,403-40% vs prior year
2026 CEO Base Salary
$500,000Increased from $300,000 in 2025
CEO 2026 Target Bonus
60%Expressed as a percentage of base salary
CEO 2025 Total Compensation
$741,403Down from prior year
Interim CFO Salary
$480,000Maintained in 2025 and 2026

How Rieger was paid

$741,403 in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary40%Option awards47%Non-equity incentive10%All other compensation2%

Named executive officers

ExecutiveTotal
Jayson RiegerPresident and Chief Executive Officer$741,403
John J. KirbyInterim Chief Financial Officer$614,600
Noah RosenbergChief Medical Officer$347,588
Christopher G. HayesFormer Chief Legal Officer$747,579
Gary GoldenbergFormer Chief Medical Officer$363,127

What changed and why

  • $1.2MCEO total compensation decreased from $1,236,225 in 2024 to $741,403 in 2025.
  • $500KJayson Rieger's base salary for 2026 was set at $500,000, up from $300,000 in 2025.
  • The compensation committee decided not to award executive bonuses based on corporate performance goals for 2025.
  • $10,000Discretionary bonuses of $10,000 and $25,000 were awarded to Mr. Kirby and Dr. Rosenberg for 2025.
  • $466KChristopher G. Hayes received $466,000 in accrued severance payments following his resignation as Chief Legal Officer.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.